Qiming Venture PartnersQiming Venture Partners Becomes a UN PRI SignatoryChina’s leading venture capital firm Qiming Venture Partners announced its recent signing of the United Nations-supported Principles for…Feb 26Feb 26
Qiming Venture PartnersEpigenic Therapeutics Announces $32 Million in Series A Funding to Bring Breakthrough Epigenome…Epigenic Therapeutics, a leading biotechnology company dedicated to developing next-generation gene modulation therapy utilizing epigenome…Aug 30, 2023Aug 30, 2023
Qiming Venture PartnersQiming Venture Partners Monthly Newsletter — April 2023Check out our 2023 April QMNewsletterMay 12, 2023May 12, 2023
Qiming Venture PartnersQiming Venture Partners Nisa Leung and Duane Kuang Made the 2023 Forbes Midas ListIn 2022, Qiming invested in more than 90 companies and welcomed 40 IPOs in the last 24 months.May 5, 2023May 5, 2023
Qiming Venture PartnersQiming Venture Partners’ portfolio company MedSci successfully listed on HKEX main boardMedSci’s successful listing is the sixth IPO that Qiming has welcomed since 2023.Apr 27, 2023Apr 27, 2023
Qiming Venture PartnersQiming Venture Partners Monthly Newsletter — March 2023Check out our 2023 March QMNewsletter!Apr 4, 2023Apr 4, 2023
Qiming Venture PartnersQiming Venture Partners Welcomes Apollomics’ Successful IPO on NasdaqApollomics’ IPO marks Qiming’s 5th IPO since 2023.Mar 31, 2023Mar 31, 2023
Qiming Venture PartnersWorld’s First Quadrivalent COVID-19 Vaccine Developed by SinocellTech is Approved for Emergency…SCTV01E is SinocellTech’s second COVID-19 vaccine product to be approved for emergency use in China after SCTV01CMar 23, 2023Mar 23, 2023
Qiming Venture PartnersQiming Venture Partners led two consecutive funding rounds in next-generation precision medicine…Allorion is a biotech company focusing on next-generation precision medicine for oncology and autoimmune diseases.Mar 13, 2023Mar 13, 2023
